Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population ; volume:9 ; number:1 ; day:16 ; month:7 ; year:2009 ; pages:1-9 ; date:12.2009
BMC urology ; 9, Heft 1 (16.7.2009), 1-9, 12.2009
- Urheber
-
Rochester, Mark A.
- Beteiligte Personen und Organisationen
-
Pashayan, Nora
Matthews, Fiona
Doble, Andrew
McLoughlin, John
SpringerLink (Online service)
- DOI
-
10.1186/1471-2490-9-7
- URN
-
urn:nbn:de:1111-2016071623995
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rochester, Mark A.
- Pashayan, Nora
- Matthews, Fiona
- Doble, Andrew
- McLoughlin, John
- SpringerLink (Online service)
Ähnliche Objekte (12)
Characterization of prostate cancer detected at repeat biopsy
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy
Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy
A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy
Prostate biopsy interpretation : an illustrated guide
A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy
Importance of biopsy sample length for cancer diagnosis during trans-perineal prostate biopsy
Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy
Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither?
Characterization of prostate cancer detected at repeat biopsy
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy
Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy
A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy
Prostate biopsy interpretation : an illustrated guide
A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy
Importance of biopsy sample length for cancer diagnosis during trans-perineal prostate biopsy
Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy
Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither?
Characterization of prostate cancer detected at repeat biopsy
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy
Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy
A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy
Prostate biopsy interpretation : an illustrated guide
A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy
Importance of biopsy sample length for cancer diagnosis during trans-perineal prostate biopsy
Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy